Open NowBusiness
Biomedical Translation Fund
Australian Government · Australia
The Biomedical Translation Fund provides equity co-investment venture capital to early-stage biomedical companies through three licensed private sector fund managers. It supports the development and commercialisation of biomedical discoveries into products, services and outcomes that improve health and wellbeing.
Deadline
Rolling / Ongoing
Location
Australia
Who Can Apply
• Be an early-stage biomedical company seeking equity investment
• At the time of first investment, already be working on a biomedical discovery or plan to work on one through a BTF investment
• Have a majority of employees and assets inside Australia, or plan to use the whole of the initial investment within Australia
• Have average annual revenue over the previous two years below 25000000 per year
• Have an Australian Business Number (ABN)
• Be incorporated under the Corporations Act 2001
• Provide all goods or services produced to persons who are not Associates
• Meet the eligible investee company criteria assessed by a licensed BTF fund manager
At the time of the first investment, the company must already be working on a biomedical discovery or plan to work on a biomedical discovery through a BTF investment. The company should either have a majority of its employees and assets inside Australia or plan to use the whole of the initial investment within Australia. It must have average annual revenue below $25 million per year over the previous two years, have an Australian Business Number, be incorporated under the Corporations Act 2001, and provide all goods or services it produces to persons who are not Associates. Investment decisions are made by licensed private sector fund managers and not all eligible companies will receive investment.
What's Funded
Equity investment to develop and commercialise biomedical discoveries, including therapeutic, medical or pharmaceutical products, processes, services, digital health services, technologies or procedures.Expected Outcomes
Commercialised biomedical discoveries, growth of Australian biomedical companies, and improved health and wellbeing of Australians through prevention, diagnosis and treatment innovations.Key Information
Applicant Types
company
Stage
early_stage
Funding Purposes
commercialisationinnovationresearch
Keywords
biomedicalventure capitalequity investmentcommercialisationhealth and medical researchdigital healthmedical technologypharmaceutical
Frequently Asked Questions
1
What is the Biomedical Translation Fund?
The Biomedical Translation Fund is a business grant offered by Australian Government in Australia. The Biomedical Translation Fund provides equity co-investment venture capital to early-stage biomedical companies through three licensed private sector fund managers. It supports the development and commercialisation of biomedical discoveries into products, services and outcomes that improve health and wellbeing.
2
Who is eligible for the Biomedical Translation Fund?
- Be an early-stage biomedical company seeking equity investment
- At the time of first investment, already be working on a biomedical discovery or plan to work on one through a BTF investment
- Have a majority of employees and assets inside Australia, or plan to use the whole of the initial investment within Australia
- Have average annual revenue over the previous two years below 25000000 per year
- Have an Australian Business Number (ABN)
- Be incorporated under the Corporations Act 2001
- Provide all goods or services produced to persons who are not Associates
- Meet the eligible investee company criteria assessed by a licensed BTF fund manager
3
What activities are funded?
Equity investment to develop and commercialise biomedical discoveries, including therapeutic, medical or pharmaceutical products, processes, services, digital health services, technologies or procedures.
4
How do I apply for the Biomedical Translation Fund?
Start by checking your eligibility using the free Beta Docs eligibility checker. If eligible, Beta Docs' AI-powered platform can help you draft, review, and refine your application to maximise your chances of success.
Need help applying?
Beta Docs has helped founders secure $160M+ in competitive grants. Our AI platform drafts compliance-perfect applications — and our expert reviewers make sure you stand out.